-First Post It is impossible to talk about Indian publishing without discussing Samir Jain, whose invisible hand  guided The Times of India group to become  India’s – and probably the world’s – most profitable media company. Despite its relatively small size in the global league (Rupert Murdoch’s NewsCorp is 20 times bigger in terms of revenues), Jain’s Bennett, Coleman & Co Ltd (BCCL) packs a huge punch and is Indian publishing’s...

-Economic and Political Weekly The recent Comptroller and Auditor General's report on the Atomic Energy Regulatory Board and, more broadly, on nuclear safety regulation has highlighted many serious organisational and operational flaws. The report follows on a series of earlier CAG reports that documented cost and time overruns and poor performance at a number of nuclear facilities in the country. On the whole, the CAG reports offer a powerful indictment of...

-The Hindu Caste discrimination takes on insidious forms in higher education institutions across the country, according to a report When 35 medical students — all Scheduled Caste candidates — failed en masse in the same subject — Physiology — they cried foul. Delhi’s Vardhman Mahavir Medical College, where they were studying, turned a deaf ear to their grievances, according to a recently-released report by Rajya Sabha MP Bhalchandra Mungekar, who was appointed...

-The Times of India A new scam worth several thousands of crores has come to light. The Central Bureau of Investigation has started a probe into serious irregularities in awarding offshore mining blocks to private companies which did not fulfill the eligibility criteria. The CBI has registered a preliminary enquiry (PE) against officials of the Indian Bureau of Mines (IBM), the ministry of mines as well as private companies which secured licences...

-The Times of India Mumbai: Consumers can look forward to a reduction in prices of essential medicines, with the Sharad Pawar-led Group of Ministers (GoM) planning to take a final decision on the pharmaceutical policy soon. The GoM will meet on September 27 to examine options under the market price-based mechanism to cap prices of drugs, which may lead to a reduction ranging from 25% to even 90% in some cases,...